|
Zydus Lifesciences Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
119842.47 Cr.
|
P/BV
|
4.42
|
Book Value (Rs.)
|
269.43
|
|
52 Week High/Low (Rs.)
|
1182/836
|
FV/ML
|
1/1
|
P/E(X)
|
23.78
|
|
Bookclosure
|
24/07/2026
|
EPS (Rs.)
|
50.09
|
Div Yield (%)
|
0.08
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 14214.80 | 12504.90 | 11413.70 | 11160.10 | 9871.60 |
| Other Operating Income | 236.70 | 192.00 | 383.30 | 284.40 | 167.40 |
| Total Income From Operations | 14451.50 | 12696.90 | 11797.00 | 11444.50 | 10039.00 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 2563.60 | 2546.00 | 2190.90 | 2182.00 | 2273.50 |
| Purchase of Traded Goods | 1823.20 | 1247.30 | 1143.70 | 1006.30 | 1002.30 |
| Increase/Decrease in Stocks | -574.20 | -313.30 | -54.10 | -130.80 | -195.80 |
| Employees Cost | 2378.50 | 2039.40 | 1917.90 | 1762.70 | 1654.30 |
| Depreciation | 868.00 | 540.00 | 466.90 | 448.90 | 400.10 |
| Other Expenses | 3889.60 | 3073.20 | 3085.50 | 3078.90 | 2571.80 |
| Total Expenses | 10948.70 | 9132.60 | 8750.80 | 8348.00 | 7706.20 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 3502.80 | 3564.30 | 3046.20 | 3096.50 | 2332.80 |
| Other Income | 245.60 | 263.90 | 138.10 | 131.40 | 194.10 |
| P/L Before Interest, Excpt. Items & Tax | 3748.40 | 3828.20 | 3184.30 | 3227.90 | 2526.90 |
| Interest | 252.90 | 186.00 | 108.60 | 57.30 | 54.40 |
| P/L Before Exceptional Items & Tax | 3495.50 | 3642.20 | 3075.70 | 3170.60 | 2472.50 |
| Exceptional Items | -482.40 | -34.20 | -219.60 | 0.00 | 0.00 |
| P/L Before Tax | 3013.10 | 3608.00 | 2856.10 | 3170.60 | 2472.50 |
| Tax | 706.70 | 888.00 | 602.70 | 809.20 | 535.00 |
| P/L After Tax from Ordinary Activities | 2306.40 | 2720.00 | 2253.40 | 2361.40 | 1937.50 |
| Extra Ordinary Item | 0.00 | 0.00 | -0.30 | 0.30 | 25.00 |
| Net Profit/Loss For the Period | 2306.40 | 2720.00 | 2253.10 | 2361.70 | 1962.50 |
| Minority Interest | -49.30 | -34.20 | -72.80 | -71.60 | 0.00 |
| Share Of P/L Of Associates | 57.50 | 39.60 | 16.80 | 41.00 | 73.50 |
| Net P/L After Minority Interest & Share Of Associates | 2314.60 | 2725.40 | 1170.90 | 2331.10 | 2036.00 |
| | | | | | |
| Equity Share Capital | 100.60 | 100.60 | 100.60 | 100.60 | 100.60 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 22.93 | 27.09 | 22.40 | 23.17 | 19.51 |
| Diluted EPS (Rs.) | 22.93 | 27.09 | 22.40 | 23.17 | 19.26 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 22.93 | 27.09 | 22.40 | 23.17 | 19.51 |
| Diluted EPS (Rs.) | 23.01 | 27.09 | 11.64 | 23.17 | 20.24 |
| | | | | | |
| PBITOE Margin (%) | 24.23 | 28.07 | 25.82 | 27.05 | 23.23 |
| PBTE Margin (%) | 24.18 | 28.68 | 26.07 | 27.70 | 24.62 |
| PBT Margin (%) | 20.84 | 28.41 | 24.21 | 27.70 | 24.62 |
| PAT Margin (%) | 15.95 | 21.42 | 19.09 | 20.63 | 19.54 |
| PAT After MI And SOA Margin (%) | 16.01 | 21.46 | 9.92 | 20.36 | 20.28 |
